Hiroaki Sasakawa
Nagoya City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroaki Sasakawa.
Structure | 2003
Wenzhen Jin; Ohki Kambara; Hiroaki Sasakawa; Atsuo Tamura; Shoji Takada
De novo sequence design of foldable proteins provides a way of investigating principles of protein architecture. We performed fully automated sequence design for a target structure having a three-helix bundle topology and synthesized the designed sequences. Our design principle is different from the conventional approach, in that instead of optimizing interactions within the target structure, we design the global shape of the protein folding funnel. This includes automated implementation of negative design by explicitly requiring higher free energy of the denatured state. The designed sequences do not have significant similarity to those of any natural proteins. The NMR and CD spectroscopic data indicated that one designed sequence has a well-defined three-dimensional structure as well as alpha-helical content consistent with the target.
Proceedings of the National Academy of Sciences of the United States of America | 2010
Miho Nishio; Yukiko Kamiya; Tsunehiro Mizushima; Soichi Wakatsuki; Hiroaki Sasakawa; Kazuo Yamamoto; Susumu Uchiyama; Masanori Noda; Adam R. McKay; Kiichi Fukui; Hans-Peter Hauri; Koichi Kato
Combined deficiency of coagulation factors V and VIII (F5F8D), an autosomal recessive disorder characterized by coordinate reduction in the plasma levels of factor V (FV) and factor VIII (FVIII), is genetically linked to mutations in the transmembrane lectin ERGIC-53 and the soluble calcium-binding protein MCFD2. Growing evidence indicates that these two proteins form a complex recycling between the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment and thereby function as a cargo receptor in the early secretory pathway of FV and FVIII. For better understanding of the mechanisms underlying the functional coordination of ERGIC-53 and MCFD2, we herein characterize their interaction by x-ray crystallographic analysis in conjunction with NMR and ultracentrifugation analyses. Inspection of the combined data reveals that ERGIC-53-CRD binds MCFD2 through its molecular surface remote from the sugar-binding site, giving rise to a 1∶1 complex in solution. The interaction is independent of sugar-binding of ERGIC-53 and involves most of the missense mutation sites of MCFD2 so far reported in F5F8D. Comparison with the previously reported uncomplexed structure of each protein indicates that MCFD2 but not ERGIC-53-CRD undergoes significant conformational alterations upon complex formation. Our findings provide a structural basis for the cooperative interplay between ERGIC-53 and MCFD2 in capturing FV and FVIII.
Journal of Molecular Biology | 2010
Yoshiki Yamaguchi; Masami Masuda; Hiroaki Sasakawa; Takashi Nonaka; Shinya Hanashima; Shin-ichi Hisanaga; Koichi Kato; Masato Hasegawa
alpha-Synuclein is a major component of filamentous inclusions that are histological hallmarks of Parkinsons disease and other alpha-synucleinopathies. Previous analyses have revealed that several polyphenols inhibit alpha-synuclein assembly with low micromolar IC(50) values, and that SDS-stable, noncytotoxic soluble alpha-synuclein oligomers are formed in their presence. Structural elucidation of inhibitor-bound alpha-synuclein oligomers is obviously required for the better understanding of the inhibitory mechanism. In order to characterize inhibitor-bound alpha-synucleins in detail, we have prepared alpha-synuclein dimers in the presence of polyphenol inhibitors, exifone, gossypetin, and dopamine, and purified the products. Peptide mapping and mass spectrometric analysis revealed that exifone-treated alpha-synuclein monomer and dimer were oxidized at all four methionine residues of alpha-synuclein. Immunoblot analysis and redox-cycling staining of endoproteinase Asp-N-digested products showed that the N-terminal region (1-60) is involved in the dimerization and exifone binding of alpha-synuclein. Ultra-high-field NMR analysis of inhibitor-bound alpha-synuclein dimers showed that the signals derived from the N-terminal region of alpha-synuclein exhibited line broadening, confirming that the N-terminal region is involved in inhibitor-induced dimerization. The C-terminal portion still predominantly exhibited the random-coil character observed in monomeric alpha-synuclein. We propose that the N-terminal region of alpha-synuclein plays a key role in the formation of alpha-synuclein assemblies.
FEBS Letters | 2010
Hiroaki Sasakawa; Yoshiki Yamaguchi; Momoe Maeda; Hiroshi Kubota; Koichi Kato; Kazuhiro Nagata
ARMET is an endoplasmic reticulum (ER) stress‐inducible protein that is required for maintaining cell viability under ER stress conditions. However, the exact molecular mechanisms by which ARMET protects cells are unknown. Here, we have analyzed the solution structure of ARMET. ARMET has an entirely α‐helical structure, which is composed of two distinct domains. Positive charges are dispersed on the surfaces of both domains and across a linker structure. Trypsin digestion and 15N relaxation experiments indicate that the tumbling of the N‐terminal and C‐terminal domains is effectively independent. These results suggest that ARMET may hold a negatively charged molecule using the two positively charged domains.
FEBS Letters | 2012
Yukiko Kamiya; Yoshinori Uekusa; Akira Sumiyoshi; Hiroaki Sasakawa; Takeshi Hirao; Tadashi Suzuki; Koichi Kato
PNGase and HR23B bind by nuclear magnetic resonance (View interaction)
FEBS Letters | 2014
Tadashi Satoh; Akira Sumiyoshi; Maho Yagi-Utsumi; Eri Sakata; Hiroaki Sasakawa; Eiji Kurimoto; Yoshiki Yamaguchi; Wei Li; Claudio A. P. Joazeiro; Takatsugu Hirokawa; Koichi Kato
Ataxin‐3, which is encoded by a gene that has been associated with Machado–Joseph disease, contains a catalytic N‐terminal Josephin domain with deubiquitinase activity. Here, we show that the Josephin domain of ataxin 3 catalyzes endo‐type cleavage of Lys48‐linked polyubiquitin. Furthermore, NMR data obtained following site‐specific paramagnetic spin labeling of Lys48‐linked di‐ubiquitin revealed that both ubiquitin units interact with the Josephin domain, with the C‐terminal Gly76 of the proximal unit being situated in the vicinity of the catalytic triad of Josephin domain. Our results help to elucidate how the substrate is recognized by the Josephin domain and properly positioned for an endo‐type deubiquitination reaction.
Biomolecular Nmr Assignments | 2012
Yoshinori Uekusa; Syunsuke Mimura; Hiroaki Sasakawa; Eiji Kurimoto; Eri Sakata; Serve Olivier; Hirokazu Yagi; Fuminori Tokunaga; Kazuhiro Iwai; Koichi Kato
HOIL-1L and its binding partner, HOIL-1L interacting protein (HOIP), are essential components of linear ubiquitin (Ub) chain assembly complex (LUBAC), a 600-kDa enzyme complex catalyzing elongation of a tandemly connected Ub chain, which serve as a regulator of NF-κB activation. Specific interaction between the N-terminal Ub-like domain (UBL) of HOIL-1L and the Ub-associated domain (UBA) located at the central region of HOIP is shown to be involved in the formation of LUBAC. For better understanding of the mechanisms underlying the generation of the linear Ub chains by LUBAC, it is necessary to characterize the UBL-UBA interaction on the basis of structural data, which, however, is not available to date. Here we report backbone and side chain NMR assignments of the UBL of human HOIL-1L. By inspection of chemical shift index, it was predicted that HOIL-1L-UBL assumes a Ub fold followed by an α-helical segment, offering the basis for determination its 3D structure and interaction with HOIP-UBA in solution.
conference on lasers and electro optics | 2001
Kohji Yamamoto; Keisuke Tominaga; Hiroaki Sasakawa; Akira Tamura; H. Murakami; H. Ohtake; Nobuhiko Sarukura
Terahertz radiation was applied to measurements of far infrared absorption spectra of polypeptides of glycine and L-alanine and cytochrome c in the native and denatured states to investigate collective modes in biopolymers.
Journal of Molecular Biology | 2007
Shigeki Matsumiya; Yoshiki Yamaguchi; Jun-ichi Saito; Mayumi Nagano; Hiroaki Sasakawa; Shizuo Otaki; Mitsuo Satoh; Kenya Shitara; Koichi Kato
Biochimica et Biophysica Acta | 2006
Yoshiki Yamaguchi; Mamiko Nishimura; Mayumi Nagano; Hirokazu Yagi; Hiroaki Sasakawa; Kazuhisa Uchida; Kenya Shitara; Koichi Kato